Pfizer wants to party with docs online

Pfizer is crashing an online party for physicians. The drug maker has inked a deal with Sermo, a sort of Facebook for docs who want to gossip about their practices--drug side effects included. Originally intended to be a "no pharma" zone where doctors could be frank about drugs, the site now will allow Pfizer medical staff to listen in on postings and contribute to the conversation, too. The rest of Pfizer's employees would be persona non grata.

Sermo officials said members recently expressed a wish for input from the pharma industry. And Pfizer wants to tap into the online-networking zeal that has made MySpace a cultural touchstone. Though Pfizer is the first drug maker to get into this "in crowd," it won't be the last; Sermo says it's working on similar deals with other companies. But the site still won't let pharma firms advertise.

- see the release from Sermo
- check out this Boston Channel article
- read about possible effects on industry communication with doctors

Suggested Articles

Despite having lost some of its novelty, AZ's Brilinta is touting bleeding data over aspirin that could be a big break in acute coronary syndrome.

More than a year after J&J and Bayer pulled the plug on Xarelto in patients after a rare valve replacement, the pair are still seeking answers.

Having already whiffed on one crucial heart failure trial, Novartis is focusing on "profound" data from its Entresto studies in hopes for another go.